PTEN and glioblastoma: To verify the clinical value of our newly established risk model and prognostic genes, we firstly calculated and found that risk scores were higher in the PTEN-mut than in the PTEN-wt subgroup both in GBM and LGG patients (Supplementary Figure 5A).